Fadraciclib is a pharmaceutical raw material under investigation as a CDK inhibitor. It is being studied in clinical trials for its potential role in targeting specific cyclin-dependent kinases.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Fadraciclib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Tosufloxacin monohydrate
pharmaceutical raw material
Perindopril erbumine
pharmaceutical raw material
Cevimeline hydrochloride
pharmaceutical raw material
Ixazomib
pharmaceutical raw material
The international HS code for Fadraciclib (CAS 1070790-89-4) is 2933.59.
2933.59
2933 59 95
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
(2R,3S)-3-[[6-[(4,6-dimethyl-3-pyridinyl)methylamino]-9-propan-2-ylpurin-2-yl]amino]pentan-2-ol
DLPIYBKBHMZCJI-WBVHZDCISA-N
CC[C@@H]([C@@H](C)O)NC1=NC(=C2C(=N1)N(C=N2)C(C)C)NCC3=CN=C(C=C3C)C
Sourcing Fadraciclib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.